Compare MYGN & CARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MYGN | CARE |
|---|---|---|
| Founded | 1991 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.6M | 438.9M |
| IPO Year | 1996 | 2020 |
| Metric | MYGN | CARE |
|---|---|---|
| Price | $4.66 | $19.95 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $7.64 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 161.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 30.19 |
| EPS | N/A | ★ 1.38 |
| Revenue | ★ $771,400,000.00 | $20,315,000.00 |
| Revenue This Year | $7.19 | $12.50 |
| Revenue Next Year | $5.64 | $9.72 |
| P/E Ratio | ★ N/A | $14.54 |
| Revenue Growth | 2.33 | ★ 4.65 |
| 52 Week Low | $3.76 | $13.61 |
| 52 Week High | $10.32 | $22.51 |
| Indicator | MYGN | CARE |
|---|---|---|
| Relative Strength Index (RSI) | 41.35 | 33.33 |
| Support Level | $3.93 | $19.32 |
| Resistance Level | $5.63 | $20.36 |
| Average True Range (ATR) | 0.42 | 0.57 |
| MACD | 0.04 | -0.17 |
| Stochastic Oscillator | 21.43 | 15.28 |
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.